This post is from a suggested group
Restoring Vision for Patients with Retinal Degenerative Diseases through Breakthrough Bioelectronic Technology in the Artificial Retina Implant Market
The Artificial Retina Implant Market represents a remarkable breakthrough in bioelectronic medicine, offering a treatment pathway for patients suffering from severe vision loss due to outer retinal degenerative diseases like Retinitis Pigmentosa (RP) and Age-related Macular Degeneration (AMD). These implants, or bionic eyes, work by bypassing the damaged photoreceptors and electrically stimulating the remaining viable retinal cells (ganglion cells) to transmit visual information to the brain. The system typically involves an external camera mounted on eyeglasses that captures the visual scene, a processor that converts the image into electrical signals, and the surgically implanted electrode array on or under the retina. While the resulting vision is often low-resolution (phosphenes), it can provide crucial light, shape, and motion perception, significantly improving a patient's independence and quality of life. This intersection of microelectronics and biology is driving…
